Cargando…
Physicians' choices in the first- and second-line management of type 2 diabetes in the Kingdom of Saudi Arabia
OBJECTIVES: The DISCOVER study is a global, prospective, three- year- observational (non-interventional) study that was conducted in 37 countries throughout the world including Saudi Arabia and aimed to assess variations in treatment patterns and therapeutic outcomes in type 2 diabetic patients. The...
Autores principales: | Al-Rubeaan, Khalid, Bana, Faisal A., Alruwaily, Fayez G., Sheshah, Eman, Alnaqeb, Dhekra, AlQahtani, Awad M., Ewais, Diaa, Al Juhani, Nassr, Hassan, Abdul-hameed, Youssef, Amira M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078533/ https://www.ncbi.nlm.nih.gov/pubmed/32194335 http://dx.doi.org/10.1016/j.jsps.2020.01.014 |
Ejemplares similares
-
Metabolic control and incidence of hypoglycaemia, hospitalisation and complications among Saudi patients with type 2 diabetes initiating second-line therapy: an analysis of the Saudi Arabia data from the DISCOVER Observational Study programme
por: Al Rubeaan, Khalid, et al.
Publicado: (2023) -
Risk Factors for Thyroid Dysfunction among Type 2 Diabetic Patients in a Highly Diabetes Mellitus Prevalent Society
por: Al-Geffari, Metab, et al.
Publicado: (2013) -
Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients
por: Al-Rubeaan, Khalid, et al.
Publicado: (2017) -
Diabetic Nephropathy and Its Risk Factors in a Society with a Type 2 Diabetes Epidemic: A Saudi National Diabetes Registry-Based Study
por: Al-Rubeaan, Khalid, et al.
Publicado: (2014) -
Association of urinary non-albumin protein with the different urinary marker for glomerular and tubular damage in patients with type 2 diabetes
por: Siddiqui, Khalid, et al.
Publicado: (2020)